Competitive Generic Therapies Get Help With Development, But Not Goal Date
Draft guidance says US FDA will try to expedite assessment of competitive generic therapy designees, but will not give shorter review goals.
Draft guidance says US FDA will try to expedite assessment of competitive generic therapy designees, but will not give shorter review goals.